Pulse Biosciences Inc (PLSE): Kapitalisasi marang pendapatan
Diversified component supply channels ensure high margins for Pulse Biosciences, Inc. (PLSE). The technological superiority of nanopulse systems and patent protection create significant barriers to entry for competitors. The P/S ratio history confirms the market valuation, where 2568.90 forms the current metric. Stable operation of the electroporation device assembly lines guarantees a steady increase in production volumes.
Rincian analitis perusahaan Pulse Corp (PLSE)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Pulse Biosciences, Inc.|PLSE - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Pulse Medical|PLSE - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Pulse Corp|PLSE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Pulse Biosciences|Rasio jangkoan perantara pulsebiosciences.com
- data bathi lan kelipatan valuasi:
PLSE - Bathi resik|Bathi resik sing dikarepake Pulse Biosciences, Inc.|PLSE - Rasio rega marang bathi|Pangali forward rega marang bathi Pulse Biosciences Inc|PLSE - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Pulse Corp|PLSE - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Pulse Biosciences|PLSE - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan pulsebiosciences.com|PLSE - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Pulse Biosciences, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:PLSE pulsebiosciences.com
Investors face a choice between overpaying for future growth and the risk of missing an asset during its expansion phase. By analyzing the price-to-sales ratio, you evaluate the market value per unit of sales, which is critical for Pulse Biosciences, Inc. (PLSE), as its diversification into cardiology and oncology reduces commercial risks and justifies specific multiples when bringing nanosecond technologies to market.
Pesaing Pulse Biosciences, Inc.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|INMD (InMode) - Multiplikator P/S|Picard Medical Corp (PMI) - Koefisien rega marang pendapatan|Multiplikator P/S SRDX|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|Rasio rega marang dodolan SSKN (STRATA Skin Sciences, Inc.)|Kapitalisasi marang pendapatan GCTK|Multiplikator P/S nanovibronix.com|Rasio rega marang pendapatan Venus Concept Corp (VERO)|Rasio rega marang pendapatan NUWE (Nuwellis Corp)|Rasio rega marang pendapatan Aethlon Medical AEMD|Koefisien rega marang pendapatan Asensus Surgical Inc (ASXC)|Avinger - Multiplikator P/S|Rega marang dodolan BioSig|CUTR (Cutera, Inc) - Kapitalisasi marang pendapatan|Know Labs Corporation - Rasio kapitalisasi pasar marang pendapatan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Rasio rega marang pendapatan NVRO|Multiplikator P/S RSLS|Koefisien rega marang pendapatan Silk Road Medical, Inc.
